Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: J Low Genit Tract Dis. 2013 Apr;17(5 0 1):S64–S68. doi: 10.1097/LGT.0b013e3182854399

Table 1.

Distribution of worst histologic diagnosis over 2003–2010 among women aged 21–24 at baseline by baseline Pap result (with HPV test triage of ASC-US).

Baseline Pap and HPV test result Total
Worst histologic diagnosis during follow-up
n <CIN1, n CIN1, n CIN2, n CIN3, n AIS, n Total CIN3 or AIS, n Squamous carcinoma, n Adeno-carcinoma, n Total cancers, n
Total 133,947 128,608 3,840 1,078 406 11 418 1 2 3
HSIL 251 114 33 60 43 0 44 0 0 0
ASC-H 454 232 91 84 46 1 47 0 0 0
AGC 87 57 17 7 4 1 5 0 1 1
LSIL 4,810 3,325 1,149 259 77 0 77 0 0 0
ASC-US 11,280 8,647 1,953 499 176 4 180 1 0 1
 HPV-positive/ASC-US 6,976 4,611 1,750 451 159 4 163 1 0 1
 HPV-negative/ASC-US 3,680 3,517 125 31 7 0 7 0 0 0
 HPV-unknown/ASC-US 624 519 78 17 10 0 10 0 0 0
Pap-negative 117,065 116,233 597 169 60 5 65 0 1 1

Footnote: Total cancers also includes adenosquamous carcinoma, cervical cancer of unknown histology, and cervical cancer histology unrelated to HPV infection. The category “Total CIN3 or AIS” also includes 1 woman with a diagnosis that did not differentiate between CIN3 and AIS. “<CIN1” means either that no biopsy was taken, or a biopsy was taken but only normal or metaplastic histology was diagnosed.